Sohini Das, Vinay Umarji And Virendra Singh Rawat

Stories by Sohini Das, Vinay Umarji And Virendra Singh Rawat

Indian Biz Sees Hope After Bangladesh SC Order

Indian Biz Sees Hope After Bangladesh SC Order

Rediff.com   22 Jul 2024

'Bilateral trade has suffered seriously because of the growing unrest.' 'There is a standstill on both sides amid the curfew.'

Nipah Death Puts Kerala On Alert

Nipah Death Puts Kerala On Alert

Rediff.com   22 Jul 2024

The scare of communicable diseases seems to be gripping the country with Maharashtra reporting 28 Zika cases this year, the highest since 2021.

Downpour Of Diseases In India

Downpour Of Diseases In India

Rediff.com   20 Jul 2024

Kerala has had 202 fatalities in 2024 so far. In July alone, there were 202,122 episodes of fever, 2,250 cases of dengue, 1,850 cases of mumps and several other illnesses. 10,000 cases of dengue have been reported from Karnataka. 1,000 swine flu cases have been documented in Rajasthan.

Honda 2W share rises after on-board norms compliance

Honda 2W share rises after on-board norms compliance

Rediff.com   17 Jul 2024

The battle for the top spot in the two-wheeler market is intensifying. The gap between Hero MotoCorp and Honda Motorcycle & Scooter India (HMSI) in retail sales narrowed to just 45,607 units in June. This improvement comes as HMSI has clawed back market share after dipping to a historic low of 18 per cent in May 2023. Now, the retail market shares of the two companies are 28.86 per cent and 25.54 per cent, respectively, compared to 35.54 per cent and 18.05 per cent in May 2023.

Diabetes Drug Linked To Vision Loss?

Diabetes Drug Linked To Vision Loss?

Rediff.com   16 Jul 2024

Study suggested that constant use of Semaglutide may be linked to development of a condition called non-arteritic ischemic optic neuropathy.

How Kalki's Bujji Was Born

How Kalki's Bujji Was Born

Rediff.com   1 Jul 2024

'Fun stuff does, indeed, happen on X.'

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com   28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

Rediff.com   25 Jun 2024

After reports claimed that filings in patent offices in India, the US, and Europe did not mention ICMR or its scientists, but only BBIL and its scientists, the Hyderabad-based biotechnology (biotech) company clarified that in the "rush" to develop vaccines and file appropriate patents, BBIL had missed adding ICMR's name in the original filings.

Cleaner Fuels Driving One-Fifth Of PVs Sold In India

Cleaner Fuels Driving One-Fifth Of PVs Sold In India

Rediff.com   18 Jun 2024

Auto manufacturers have focused on launching CNG variants of their popular models to meet consumer demand for vehicles with lower running costs.

'Second-gen promoters more open to selling out'

'Second-gen promoters more open to selling out'

Rediff.com   6 Jun 2024

'There is not any negative connotation associated with it.'

'Depending on the product, the pricing pressure will always be there'

'Depending on the product, the pricing pressure will always be there'

Rediff.com   3 Jun 2024

'That is a significant milestone for us and something we aspired for.'

Can Afzal Ansari Defeat BJP Again?

Can Afzal Ansari Defeat BJP Again?

Rediff.com   31 May 2024

Samajwadi Party candidate Afzal Ansari is the incumbent MP and slain don Mukhtar Ansari's elder brother. Afzal had won the 2019 election on a BSP ticket after defeating the BJP's Manoj Sinha, now the J&K lieutenant governor.

What Margin Will Modi Win Varanasi By?

What Margin Will Modi Win Varanasi By?

Rediff.com   31 May 2024

Few in Varanasi expect the result to be different from 2014 and 2019. The only point of interest is whether Narendra Modi will increase his winning margin against his rivals.

New-Gen COVID Jabs Coming Soon...

New-Gen COVID Jabs Coming Soon...

Rediff.com   28 May 2024

India currently does not have any XBB 1.5 variant-based vaccines available.

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Rediff.com   23 May 2024

Several firms are stepping up to help their workforce cope with soaring temperatures

Should Govt Continue Covid Vax Drive?

Should Govt Continue Covid Vax Drive?

Rediff.com   20 May 2024

India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities.

M&M shifts to high gear with Rs 37K cr investments

M&M shifts to high gear with Rs 37K cr investments

Rediff.com   17 May 2024

Automotive (auto) major Mahindra & Mahindra (M&M), which is readying to launch nine sport utility vehicles (internal combustion engine/ICE), seven Born Electric Vehicles (BEVs), and seven light commercial vehicles by 2030, has outlined an investment of Rs 27,000 crore in its auto business between 2024-25 (FY25) and 2026-27 (FY27). Over the next three years, the company will deploy Rs 37,000 crore, including its auto business, farm business (Rs 5,000 crore), and service business (Rs 5,000 crore).

Gut Health Key To Prevent Chronic Illnesses

Gut Health Key To Prevent Chronic Illnesses

Rediff.com   24 Apr 2024

Maintaining the balance of gut microbiota is important as an imbalance, also known as dysbiosis, can cause or aggravate different diseases, including but not limited to digestive problems such as inflammatory bowel syndrome, mental health issues like anxiety and depression and menstrual problems.

Zydus gets China nod for kidney disease drug

Zydus gets China nod for kidney disease drug

Rediff.com   24 Apr 2024

Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by the National Medical Products Administration of China (NMPA). In 2020, CMS International Development and Management Ltd, a wholly-owned subsidiary of China Medical System Holdings Ltd obtained an exclusive license for the product from Zydus. CKD involves a gradual loss of functioning of kidneys and eventually leads to kidney failure.

Consumption story gets a facelift as rural demand shows promise

Consumption story gets a facelift as rural demand shows promise

Rediff.com   16 Apr 2024

Consumer goods firms and auto companies are witnessing an upturn in rural demand, which had been lagging for most of FY24. Expectations of a bumper rabi crop harvest have helped turn the tide. The Reserve Bank of India's (RBI's) Monetary Policy Committee kept the repo rate unchanged last week, noting that as rural demand catches up, consumption is expected to support economic growth in 2024-25.